The online version of this article (https://doi.org/10.1007/s00384-019-03302-5) contains supplementary material, which is available to authorized users.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Up to 25% of colorectal cancers present with bowel obstruction. Metal stents (MS) can provide a bridge to surgery by relieving obstruction and allowing the subject’s condition to improve pre-operatively.
Hospital Episode Statistics (HES) is a database of all NHS funded secondary care episodes in England. Subjects admitted with bowel obstruction secondary to colorectal cancer without metastases were identified and subdivided into two groups: MS insertion prior to surgery and surgery only. Due to demographic differences between the groups, propensity score matching was used to analyse procedural outcomes, mortality and readmission within 30 days in left-sided cancers based upon age, sex and Charlson co-morbidity score.
Over 10 years, 4571 subjects were identified; 401 received a MS and 4170 underwent surgery only. Median age of MS subjects was 71 (IQR 62–79) years; 226 (56.4%) were male. Median age of surgery-only subjects was 73 (64–81); 2165 (51.9%) were male. Following propensity matching 375 MS and 375 surgery-only subjects remained; MS had fewer readmissions within 30 days (28 (7.5%) versus 44 (11.7%), p = 0.047), fewer respiratory complications (< 6 (< 1.5%) versus 28 (7.5%), p < 0.001), lower stoma rates (49 (13.1%) versus 159 (42.4%), p < 0.001) and higher rates of laparoscopic surgery (154 (41.1%) versus 25 (6.7%), p < 0.001). Mortality was lower in the MS group at 30 days (7 (1.9%) versus 33 (8.8%), p < 0.001) and 1 year (37 (9.9%) versus 71 (19.0%), p < 0.001).
In subjects presenting with obstructing colorectal cancer outcomes including respiratory complications, readmission and mortality appear to be better in subjects undergoing MS as a bridge to surgery compared to surgery alone.
ESM 1 (DOCX 23 kb)384_2019_3302_MOESM1_ESM.docx
Bowel Cancer Statistics. Cancer Research UK
Hospital Episode Statistics. NHS digital
Hill J, Kay C, Morton D, Magill L, Handley K, Gray RG 2016 CREST Trial Collaborative Group. CREST: Randomised phase III study of stenting as a bridge to surgery in obstructing colorectal cancer—Results of the UK ColoRectal Endoscopic Stenting Trial (CREST). J Clin Oncol :34, (suppl; abstr 3507)
Nuttal M, Van Der Meulen J, Emberton M (2006) Charlson scores based on ICD-10 adminsitrative data were valid in assessing comorbidity in patients undergoing urological cncer surgery. J Clin Epidemiol 59:265–273 CrossRef
2015 Statacorp. Stata statistical software: release 14.: TX: StataCorp LP
Arezzo A, Balague C, Targarona E, Borghi F, Giraudo G, Ghezzo L, Arroyo A, Sola-Vera J, De Paolis P, Bossotti M, Bannone E, Forcignanò E, Bonino MA, Passera R, Morino M (2016) Colonic stenting as a bridge to surgery versus emergency surgery for malignant colonic obstruction: results of a multicentre randomised controlled trial (ESCO trial). Surg Endosc
- Outcomes of colorectal stents when used as a bridge to curative resection in obstruction secondary to colorectal cancer
Philip R Harvey
Nigel J Trudgill
- Springer Berlin Heidelberg
Neu im Fachgebiet Chirurgie
e.Med Kampagnen-Visual, Mail Icon II